Portfolio Update

RNS Number : 7925F

Intl. Biotechnology Trust PLC

18 November 2020

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

Portfolio Update

The Board of International Biotechnology Trust plc (the Company) notes the following unquoted portfolio event.

The Company has received quarterly investor reporting in relation to its investment in the unlisted venture capital fund, SV Fund VI.

SV Fund VI's latest quarterly investor report values the Company's investment at $33.8m (£25.6m), an uplift of $4.8m (£4.0m) on the valuation of $29.0m (£21.6m) which was included in the Company's Net Asset Value (NAV) calculation for 31 August 2020.

In line with the Company's accounting policy, valuation movements following receipt of quarterly investor reports are reflected in the next reported NAV.  Therefore, the increase in NAV to be reported today, as at 18 November 2020, will be £4.0m or 9.1 pence per share.

Enquiries:

Telephone: [phone]

SV Health Managers LLP

Fund Manager

18 NOVEMBER 2020

 

END

 

 

PFUBRBDBLXBDGGI